Literature DB >> 2483504

Phenotype, cytotoxic, and helper functions of T cells from varicella zoster virus stimulated cultures of human lymphocytes.

A Hayward1, R Giller, M Levin.   

Abstract

Blood mononuclear cells (MNC) were stimulated with VZV in the form of live cell-associated virus, glutaraldehyde-fixed VZV-infected fibroblasts or an extracted VZV antigen. After 7 days of culture with live virus, IL2 receptors (IL2R) were found on CD4 and CD8 cells while cultures stimulated with fixed or extracted antigen had IL2R only on CD4 cells. Clones derived by limiting dilution from these cultures were tested for specificity by cytotoxicity to autologous VZV-superinfected B lymphoblasts, and by proliferation in the presence of antigen and antigen presenting cells. The CD8+ clones were not VZV specific in tests of cytotoxicity or proliferation. 50% of the CD4+ clones with specificity for VZV also proliferated in cultures stimulated with individual VZV glycoproteins gp I, II or III. Included amongst these were clones cytotoxic for lymphoblast targets prepared with live VZV. Most of the VZV-specific T cell clones which failed to lyse targets prepared with live VZV lysed targets prepared with heat killed VZV. Target cells were susceptible to lysis after VZV antigens were no longer demonstrable on the cell surface by immunofluorescence and monoclonal antibodies to VZV glycoproteins failed to block cytotoxicity. 5 of 8 VZV-specific CD4+ clones provided antigen-specific help to B cells for IgG antibody production. The data are consistent with the view that CD4+ T cells respond to processed VZV antigen fragments, and that these fragments include epitopes present on gp I, gp II and gp III. Additionally, some the cloned progeny of VZV specific T cells were bifunctional (expressing cytotoxicity and help for B cells) in tissue culture.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2483504     DOI: 10.1089/vim.1989.2.175

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  10 in total

1.  Modulation of major histocompatibility class II protein expression by varicella-zoster virus.

Authors:  A Abendroth; B Slobedman; E Lee; E Mellins; M Wallace; A M Arvin
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV.

Authors:  A R Hayward
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

3.  Immune correlates of herpes zoster in HIV-infected children and youth.

Authors:  Adriana Weinberg; Sharon Huang; Lin-Ye Song; Terry Fenton; Paige Williams; Julie Patterson; Adriana Tovar-Salazar; Myron J Levin
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

4.  V beta 5 and V beta 8 memory T cells in adults and infancy: co-ordinated increase in response to early antigen stimulus.

Authors:  A R Hayward; J Clarke; M Cosyns
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

5.  Major histocompatibility complex restriction of T-cell responses to varicella-zoster virus in guinea pigs.

Authors:  A R Hayward; R Burger; R Scheper; A M Arvin
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

6.  Specific lysis of targets expressing varicella-zoster virus gpI or gpIV by CD4+ human T-cell clones.

Authors:  Z Huang; A Vafai; J Lee; R Mahalingam; A R Hayward
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

7.  Persistent high frequencies of varicella-zoster virus ORF4 protein-specific CD4+ T cells after primary infection.

Authors:  Louise Jones; Antony P Black; Gathsaurie N Malavige; Graham S Ogg
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

8.  CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.

Authors:  Kristen Haberthur; Flora Engelmann; Byng Park; Alex Barron; Alfred Legasse; Jesse Dewane; Miranda Fischer; Amelia Kerns; Monica Brown; Ilhem Messaoudi
Journal:  PLoS Pathog       Date:  2011-11-10       Impact factor: 6.823

9.  Effector and Central Memory Poly-Functional CD4(+) and CD8(+) T Cells are Boosted upon ZOSTAVAX(®) Vaccination.

Authors:  Janet J Sei; Kara S Cox; Sheri A Dubey; Joseph M Antonello; David L Krah; Danilo R Casimiro; Kalpit A Vora
Journal:  Front Immunol       Date:  2015-10-29       Impact factor: 7.561

Review 10.  Predictors of shingles reports at diagnosis of common variable immunodeficiency and selective immunoglobulin G subclass deficiency in 212 Alabama adults.

Authors:  James C Barton; J Clayborn Barton; Luigi F Bertoli
Journal:  Infect Dis Rep       Date:  2012-07-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.